Skip to main content
All Resources
Related Topics
Umbilical Cord CareAdvocacy
Countries

Cameroon

Chad

Kenya

Liberia

Mali

Niger

Nigeria

Senegal

Regions

Africa

Organizations
World Health Organization
Subscribe to our Newsletter
Share

WHO/HQ has been made aware of over forty-five (45) reports of eye injuries, including cases of blindness, associated with the improper use of Chlorhexidine diclucanate 7.1% (CHX) in nine African countries —Nigeria (2015), Senegal (2015), DRC (2015), Liberia (2015), Niger (2017), Mali (2018), Kenya (2018), Chad (2018) and Cameroon (2019). The reported injuries are associated with both the liquid and the gel CHX formulations.

The Essential Medicines and Health Products Department (EMP) through its Safety and Vigilance Unit has issued a Drug Safety Alert. This Alert notifies the National Medicine Regulatory Authorities and those responsible for patient safety and phamacovigilance of thereported injuries associated with the misuse of CHX.

 

Related Resources

See All Resources

Journal Article

Jun 23, 2025

Advocacy | Health Systems

Born Too Soon: learning from the past to accelerate action in the next decade

Journal Article

Jun 23, 2025

Advocacy | Community

Born Too Soon: Every story counts: lessons in ethical, inclusive storytelling from born too soon

Journal Article

Jun 23, 2025

Advocacy | Maternal

Born Too Soon: Progress, priorities and pivots for preterm birth

Journal Article

Jun 23, 2025

Advocacy | Data/Statistics

Born Too Soon: Priorities to improve the prevention and care of preterm birth